Roche’s new AAN 2019 data Event
Roche has hosted a live audio webcast and conference call on Monday, 13 May 2019.
| Agenda: | |
|---|---|
| Welcome | Karl Mahler, Head of Investor Relations |
| Overview of Roche key data at AAN covering new analysis from Ocrevus, satralizumab SakuraSky phase III data, risdiplam one year part I FIREFISH and SUNFISH data and dose selection data for the phase III study in Huntington's Disease | Paulo Fontoura, Global Head Neuroscience and Rare Diseases Clinical Development |
| Roche Neuroscience and Rare Disease franchise update | Karsten Jung, Therapeutic Area Head Neuroscience and Rare Diseases |
| Q&A |